• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的2型糖尿病患者肾脏疾病临床预测因素分析

Analysis of clinical predictors of kidney diseases in type 2 diabetes patients based on machine learning.

作者信息

Hui Dongna, Sun Yiyang, Xu Shixin, Liu Junjie, He Ping, Deng Yuhui, Huang Huaxiong, Zhou Xiaoshuang, Li Rongshan

机构信息

Institute of Biomedical Sciences, Shanxi University, No. 92 Wucheng Road, Xiaodian District, Taiyuan, 030006, Shanxi, China.

Department of Nephrology, Shanxi Provincial People's Hospital, No. 29 Shuangta Street, Yingze District, Taiyuan, 030012, Shanxi, China.

出版信息

Int Urol Nephrol. 2023 Mar;55(3):687-696. doi: 10.1007/s11255-022-03322-1. Epub 2022 Sep 7.

DOI:10.1007/s11255-022-03322-1
PMID:36069963
Abstract

BACKGROUND

The heterogeneity of Type 2 Diabetes Mellitus (T2DM) complicated with renal diseases has not been fully understood in clinical practice. The purpose of the study was to propose potential predictive factors to identify diabetic kidney disease (DKD), nondiabetic kidney disease (NDKD), and DKD superimposed on NDKD (DKD + NDKD) in T2DM patients noninvasively and accurately.

METHODS

Two hundred forty-one eligible patients confirmed by renal biopsy were enrolled in this retrospective, analytical study. The features composed of clinical and biochemical data prior to renal biopsy were extracted from patients' electronic medical records. Machine learning algorithms were used to distinguish among different kidney diseases pairwise. Feature variables selected in the developed model were evaluated.

RESULTS

Logistic regression model achieved an accuracy of 0.8306 ± 0.0057 for DKD and NDKD classification. Hematocrit, diabetic retinopathy (DR), hematuria, platelet distribution width and history of hypertension were identified as important risk factors. Then SVM model allowed us to differentiate NDKD from DKD + NDKD with accuracy 0.8686 ± 0.052 where hematuria, diabetes duration, international normalized ratio (INR), D-Dimer, high-density lipoprotein cholesterol were the top risk factors. Finally, the logistic regression model indicated that DD-dimer, hematuria, INR, systolic pressure, DR were likely to be predictive factors to identify DKD with DKD + NDKD.

CONCLUSION

Predictive factors were successfully identified among different renal diseases in type 2 diabetes patients via machine learning methods. More attention should be paid on the coagulation factors in the DKD + NDKD patients, which might indicate a hypercoagulable state and an increased risk of thrombosis.

摘要

背景

2型糖尿病(T2DM)合并肾脏疾病的异质性在临床实践中尚未得到充分认识。本研究的目的是提出潜在的预测因素,以无创且准确地识别T2DM患者中的糖尿病肾病(DKD)、非糖尿病肾病(NDKD)以及NDKD合并DKD(DKD+NDKD)。

方法

本回顾性分析研究纳入了241例经肾活检确诊的合格患者。从患者的电子病历中提取肾活检前的临床和生化数据特征。使用机器学习算法对不同的肾脏疾病进行两两区分。对所开发模型中选择的特征变量进行评估。

结果

逻辑回归模型对DKD和NDKD分类的准确率为0.8306±0.0057。血细胞比容、糖尿病视网膜病变(DR)、血尿、血小板分布宽度和高血压病史被确定为重要危险因素。然后,支持向量机模型使我们能够以0.8686±0.052的准确率区分NDKD和DKD+NDKD,其中血尿、糖尿病病程、国际标准化比值(INR)、D-二聚体、高密度脂蛋白胆固醇是主要危险因素。最后,逻辑回归模型表明,D-二聚体、血尿、INR、收缩压、DR可能是识别DKD与DKD+NDKD的预测因素。

结论

通过机器学习方法成功识别了2型糖尿病患者不同肾脏疾病中的预测因素。DKD+NDKD患者的凝血因子应得到更多关注,这可能表明存在高凝状态和血栓形成风险增加。

相似文献

1
Analysis of clinical predictors of kidney diseases in type 2 diabetes patients based on machine learning.基于机器学习的2型糖尿病患者肾脏疾病临床预测因素分析
Int Urol Nephrol. 2023 Mar;55(3):687-696. doi: 10.1007/s11255-022-03322-1. Epub 2022 Sep 7.
2
Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021.2017 年至 2021 年回顾性研究:2 型糖尿病患者中非糖尿病性肾脏疾病的临床预测因子。
BMC Endocr Disord. 2022 Jun 30;22(1):168. doi: 10.1186/s12902-022-01082-8.
3
Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes.2型糖尿病患者中的非糖尿病肾病:患病率、临床预测因素及预后
Kidney Blood Press Res. 2017;42(5):886-893. doi: 10.1159/000484538. Epub 2017 Nov 1.
4
Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.基于肾活检的糖尿病肾病患者甘油三酯与胱抑素 C 比值的诊断价值:一项回顾性和前瞻性队列研究。
BMC Nephrol. 2022 Jul 27;23(1):270. doi: 10.1186/s12882-022-02888-3.
5
Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.非糖尿病性肾脏疾病的患病率以及临床预测指标无法将其与糖尿病性肾脏疾病区分开来:一项前瞻性进行的肾活检研究结果。
BMJ Open Diabetes Res Care. 2022 Dec;10(6). doi: 10.1136/bmjdrc-2022-003058.
6
Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.2 型糖尿病患者临床肾脏疾病的组织学谱,特别关注非白蛋白尿性糖尿病肾病:一项基于肾脏活检的研究。
J Assoc Physicians India. 2022 Aug;70(8):11-12. doi: 10.5005/japi-11001-0060.
7
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results.2型糖尿病患者肾活检作用的见解:全球肾活检结果的文献综述
Diabetes Ther. 2020 Sep;11(9):1983-1999. doi: 10.1007/s13300-020-00888-w. Epub 2020 Aug 5.
8
Characterizing predictors of non-diabetic kidney disease (NDKD) in diabetic patients.确定糖尿病患者非糖尿病肾病(NDKD)的预测因素。
Int Urol Nephrol. 2022 Jun;54(6):1303-1309. doi: 10.1007/s11255-021-02998-1. Epub 2021 Sep 29.
9
Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.肾动脉阻力指数在糖尿病肾病鉴别诊断中的作用。
Front Endocrinol (Lausanne). 2022 Jan 14;12:731187. doi: 10.3389/fendo.2021.731187. eCollection 2021.
10
Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.评估尿中性粒细胞明胶酶相关脂质运载蛋白对糖尿病肾病的鉴别诊断和进展的影响。
J Diabetes Complications. 2020 Oct;34(10):107665. doi: 10.1016/j.jdiacomp.2020.107665. Epub 2020 Jun 26.

引用本文的文献

1
Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis.基于机器学习的2型糖尿病患者糖尿病肾病风险预测模型:一项系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2025 Mar 3;16:1495306. doi: 10.3389/fendo.2025.1495306. eCollection 2025.
2
Real-World Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Mild-to-Moderate Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Retrospective, Single-Arm Clinical Trial.胰高血糖素样肽-1受体激动剂对2型糖尿病患者轻度至中度糖尿病肾病的真实世界临床疗效:一项回顾性单臂临床试验。
Diabetes Metab Syndr Obes. 2024 Aug 1;17:2913-2921. doi: 10.2147/DMSO.S472968. eCollection 2024.
3

本文引用的文献

1
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study.糖尿病患者非糖尿病性肾脏疾病的临床预测因素:一项单中心研究。
Int J Nephrol. 2021 Jul 12;2021:9999621. doi: 10.1155/2021/9999621. eCollection 2021.
2
Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives.2 型糖尿病患者的肾脏活检:对现有适应证和诊断替代方案的批判性思考。
Int J Mol Sci. 2021 May 21;22(11):5425. doi: 10.3390/ijms22115425.
3
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease.
Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis.中国 2 型糖尿病患者糖尿病肾病风险预测模型的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Jul 3;15:1407348. doi: 10.3389/fendo.2024.1407348. eCollection 2024.
4
Coagulation Function and Type 2 Diabetic Kidney Disease: A Real-World Observational Study.凝血功能与 2 型糖尿病肾病:一项真实世界观察性研究。
J Diabetes Res. 2023 Dec 6;2023:8848096. doi: 10.1155/2023/8848096. eCollection 2023.
5
Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria.血清抗磷酯酶 A2 受体抗体在 2 型糖尿病伴蛋白尿患者病理诊断中的作用。
Sci Rep. 2023 Oct 3;13(1):16608. doi: 10.1038/s41598-023-43766-8.
6
The Diagnostic Performance of a Clinical Diagnosis of Diabetic Kidney Disease.糖尿病肾病临床诊断的诊断效能
Life (Basel). 2023 Jun 30;13(7):1492. doi: 10.3390/life13071492.
基于生物标志物和电子患者数据的机器学习风险评分的推导和验证,以预测糖尿病肾脏疾病的进展。
Diabetologia. 2021 Jul;64(7):1504-1515. doi: 10.1007/s00125-021-05444-0. Epub 2021 Apr 2.
4
Anemia in Diabetic Patients Reflects Severe Tubulointerstitial Injury and Aids in Clinically Predicting a Diagnosis of Diabetic Nephropathy.糖尿病患者的贫血反映了严重的肾小管间质损伤,并有助于临床预测糖尿病肾病的诊断。
Intern Med. 2021 May 1;60(9):1349-1357. doi: 10.2169/internalmedicine.5455-20. Epub 2020 Nov 30.
5
Risk factors for non-diabetic renal disease in diabetic patients.糖尿病患者非糖尿病性肾脏疾病的危险因素。
Clin Kidney J. 2020 Jan 3;13(3):380-388. doi: 10.1093/ckj/sfz177. eCollection 2020 Jun.
6
Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach.2 型糖尿病患者肾活检的时机:逐步评估。
BMC Nephrol. 2020 Apr 15;21(1):131. doi: 10.1186/s12882-020-01794-w.
7
Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts.基于 20 项队列研究的系统评价和荟萃分析建立和验证早期糖尿病肾病的风险预测模型。
Diabetes Care. 2020 Apr;43(4):925-933. doi: 10.2337/dc19-1897.
8
A Differential Diagnosis Model For Diabetic Nephropathy And Non-Diabetic Renal Disease In Patients With Type 2 Diabetes Complicated With Chronic Kidney Disease.2型糖尿病合并慢性肾脏病患者糖尿病肾病与非糖尿病肾病的鉴别诊断模型
Diabetes Metab Syndr Obes. 2019 Sep 30;12:1963-1972. doi: 10.2147/DMSO.S223144. eCollection 2019.
9
Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients.设计和验证 2 型糖尿病患者糖尿病肾病与非糖尿病肾脏疾病鉴别诊断的评分模型。
J Diabetes. 2020 Mar;12(3):237-246. doi: 10.1111/1753-0407.12994. Epub 2019 Dec 2.
10
Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning.人工智能利用大数据机器学习预测糖尿病肾病的进展。
Sci Rep. 2019 Aug 14;9(1):11862. doi: 10.1038/s41598-019-48263-5.